Kamilla Miskowiak

Kamilla Miskowiak

Professor


  1. 2023
  2. Published

    Safety, Feasibility, and Potential Clinical Efficacy of 40 Hz Invisible Spectral Flicker versus Placebo in Patients with Mild-to-Moderate Alzheimer's Disease: A Randomized, Placebo-Controlled, Double-Blinded, Pilot Study

    Agger, M. P., Danielsen, E. R., Carstensen, M. S., Nguyen, N. M., Horning, M., Henney, M. A., Jensen, C. B. R., Baandrup, A. O., Kjær, T. W., Madsen, K. H., Miskowiak, Kamilla, Petersen, P. M. & Høgh, Peter, 2023, In: Journal of Alzheimer's Disease. 92, 2, p. 653-665 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Study on the effect of 40 Hz non-invasive light therapy system. A protocol for a randomized, double-blinded, placebo-controlled clinical trial

    Agger, M. P., Horning, M., Carstensen, M. S., Danielsen, E. R., Baandrup, A. O., Nguyen, M., Høgh, Peter, Miskowiak, Kamilla, Petersen, P. M., Madsen, K. H. & Kjær, T. W., 2023, In: Frontiers in Aging Neuroscience. 15, 9 p., 1250626.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    The longitudinal trajectory of emotional cognition in subgroups of recently diagnosed patients with bipolar disorder

    de Siqueira Rotenberg, L., Kjærstad, H. L., Varo, C., Vinberg, Maj, Kessing, Lars Vedel, Lafer, B. & Miskowiak, Kamilla, 2023, In: European Neuropsychopharmacology. 71, p. 9-24 16 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    The trajectory of emotional and non-emotional cognitive function in newly diagnosed patients with bipolar disorder and their unaffected relatives: A 16-month follow-up study

    Kjærstad, H. L., Søhol, K., Vinberg, Maj, Kessing, Lars Vedel & Miskowiak, Kamilla, 2023, In: European Neuropsychopharmacology. 67, p. 4-21 18 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 Next

ID: 17430636